
The in vitro activity of the antibiotic amikumacin A against 22 collective test strains and 24 clinical isolates of bacteria and fungi was studied. It is shown that amicoumycin A has a broad antimicrobial spectrum of activity. The minimum inhibitory concentration (MIC) of amicoumycin A against methicillin-resistant Staphylococcus aureus (MRSA) and resistant to glycopeptide antibiotics of vancomycin group (VR) test strain Leuconostoc mesenteroides of 0.06 ^g/disk were established. In the study of multidrug-resistant clinical isolates, amikumacin A exhibited activity against S.aureus, S.epidermidis, C.krusei, Cr.neoformis and Prototheca spp. strains.
antibiotic resistance, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, mrsa, pathogens, RC254-282, amicoumycin a
antibiotic resistance, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, mrsa, pathogens, RC254-282, amicoumycin a
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
